Talisman Therapeutics (AgeTech UK) Biomed
Treatments for neurodegenerative diseases at the molecular level. Talisman Therapeutics is committed to revolutionising the discovery of disease-modifying treatments for neurodegenerative diseases. Use cutting-edge stem cell technologies to answer the most difficult biological questions in target discovery and validation.
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership